Get the Stockscreener App
9.61
1.59%
0.15
After Hours:
9.42
-0.19
-1.98%
Embecta Corp stock is traded at $9.61, with a volume of 512.75K.
It is up +1.59% in the last 24 hours and up +9.33% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$9.46
Open:
$9.49
24h Volume:
512.75K
Relative Volume:
0.62
Market Cap:
$569.10M
Revenue:
$1.08B
Net Income/Loss:
$139.50M
P/E Ratio:
4.0523
EPS:
2.3715
Net Cash Flow:
$205.80M
1W Performance:
+8.22%
1M Performance:
+9.33%
6M Performance:
-30.76%
1Y Performance:
-19.31%
1-Day Range:
$9.38
$9.69
1-Week Range:
$8.60
$9.725
52-Week Range:
$8.47
$15.55
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
9.61 | 560.22M | 1.08B | 139.50M | 205.80M | 2.3715 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
How The Embecta (EMBC) Investment Story Is Shifting As Fair Value And Expectations Reset - Yahoo Finance
Embecta Corp stock (US29082K1051): Why does its diabetes focus matter more for U.S. investors now? - AD HOC NEWS
Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88? - Yahoo Finance
Embecta Corp stock: What investors need to know about its diabetes focus now - AD HOC NEWS
Embecta Corp. (EMBC) Stock Forecasts - Yahoo Finance
Aug Sectors: Why is Embecta Corp stock going up2026 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
embecta Welcomes New Board Chair and Lead Independent Director - Medical Product Outsourcing
Responsive Playbooks and the EMBC Inflection - Stock Traders Daily
SG Americas Securities LLC Acquires Shares of 435,842 Embecta Corp. $EMBC - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Embecta Corp Stock: A Focused Leader in Diabetes Care with Proven Products and Strategic Independenc - AD HOC NEWS
Embecta Corp (JX7.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
Embecta Corp. Stock Plummets to New 52-Week Low of $8.47 - Markets Mojo
Market Rankings: Why is Embecta Corp stock going upShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Mills & Reeve advises Owen Mumford on £150m sale to embecta Corp in New Jersey - Business Weekly
Embecta agrees to acquire Owen Mumford - MSN
Embecta Corp. Stock Plummets to New 52-Week Low of $8.68 - Markets Mojo
Vanguard reorganizes reporting; EMBC ownership listed as 0 (EMBC) - Stock Titan
Embecta (NASDAQ:EMBC) Sets New 12-Month LowTime to Sell? - MarketBeat
Understanding the Setup: (EMBC) and Scalable Risk - Stock Traders Daily
“Landmark moment” for medical device manufacturer with sale to Nasdaq-listed groupMills & Reeve advised - Insider Media Ltd
Embecta Plans Acquisition of Owen Mumford to Broaden Drug-Delivery Offerings - Bitget
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio - Zacks Investment Research
Embecta to buy Owen Mumford for up to £150M - MSN
Performance Recap: Will Embecta Corp stock go up in YEAR2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Embecta: £150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities - Pulse 2.0
Embecta rallies after UK firm deal worth $200 million - MSN
Aug Gainers: What is the PEG ratio of Embecta Corp2026 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Embecta to Acquire Owen Mumford for Up to £150 Million, Expanding Drug-Delivery Device Portfolio and Global Medical Supplies Presence 123 - Minichart
Embecta to Acquire Owen Mumford in £150M Deal, Expanding Drug Delivery and Chronic Care Portfolio - Pharmacy Times
Embecta to Acquire Owen Mumford, Expanding Drug-Delivery Portfolio - tipranks.com
Embecta (NASDAQ: EMBC) to acquire Owen Mumford in up to £150m deal - Stock Titan
Embecta to acquire Owen Mumford for up to £150 million By Investing.com - Investing.com India
Embecta Corp. agreed to acquire Owen Mumford Holdings Limited from Mark Owen, Adam Mumford, Ellen Owen, Kim Priddis,Nancy Millington and others for approximately £150 million. - MarketScreener
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - drugdeliverybusiness.com
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - Medical Product Outsourcing
Embecta acquires Owen Mumford for £150M - BioWorld MedTech
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - Medical Device and Diagnostic industry
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal By Investing.com - Investing.com Australia
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal - Investing.com UK
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):